Dyskinesias and grip control in Parkinson's disease are normalized by chronic stimulation of the subthalamic nucleus

Ann Neurol. 2002 Aug;52(2):240-3. doi: 10.1002/ana.10254.

Abstract

Deep-brain stimulation of the subthalamic nucleus appears to reduce levodopa-induced dyskinesias, but whether this effect is caused by the reduction of the total levodopa ingestion or represents a direct effect on the motor system is unknown. Precision grip force of grasping movements and levodopa-induced dyskinesias was analyzed in 10 parkinsonian patients before and after 3 months of deep-brain stimulation of the subthalamic nucleus. Peak grip force was abnormally increased before surgery in the off-drug state and, particularly, in the on-drug state (sensitization). This grip force upregulation normalized with chronic deep-brain stimulation in both conditions (desensitization). Peak-dose dyskinesias also improved, and off-dystonia was completely abolished. Mean dosage of dopaminergic drugs was reduced, but force overflow and dyskinesias were equally improved in 2 patients without a reduction. Despite the same single levodopa test dose, force excess and levodopa-induced dyskinesias were drastically reduced after 3 months of deep-brain stimulation of the subthalamic nucleus. This indicates that direct effects of deep-brain stimulation of the subthalamic nucleus on levodopa-induced dyskinesias are likely to occur. Grip force overflow is a promising parameter to study the desensitizing effect of chronic deep-brain stimulation on levodopa-induced dyskinesias.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Dyskinesias / etiology
  • Dyskinesias / physiopathology*
  • Dyskinesias / therapy*
  • Electric Stimulation Therapy*
  • Hand Strength*
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / therapeutic use
  • Parkinson Disease / complications*
  • Reference Values
  • Severity of Illness Index
  • Subthalamic Nucleus / physiopathology*
  • Time Factors

Substances

  • Levodopa